Cargando…
Illicit Drug Use and Risk for USA300 Methicillin-Resistant Staphylococcus aureus Infections with Bacteremia
Autores principales: | Kreisel, Kristen M., Johnson, J. Kristie, Stine, O. Colin, Shardell, Michelle D., Perencevich, Eli N., Lesse, Alan J., Gordin, Fred M., Climo, Michael W., Roghmann, Mary-Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294968/ https://www.ncbi.nlm.nih.gov/pubmed/20735927 http://dx.doi.org/10.3201/eid1609.091802 |
Ejemplares similares
-
Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus USA300 Clone
por: Johnson, Jennifer K., et al.
Publicado: (2007) -
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
por: Carrel, Margaret, et al.
Publicado: (2015) -
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011) -
Hospital-Related Lineage of USA300 Methicillin-Resistant Staphylococcus aureus (MRSA) to Cause Bacteremia in Iran
por: Navidinia, Masoumeh, et al.
Publicado: (2023) -
USA300 Methicillin-resistant Staphylococcus aureus in Cuba
por: Hopman, Joost, et al.
Publicado: (2012)